Joint replacements are the #1 expenditure of Medicare. The process of approving these medical devices is flawed according to the Institute of Medicine. It is time for patients' voices to be heard as stakeholders and for public support for increased medical device industry accountability and heightened protections for patients. Post-market registry. Product warranty. Patient/consumer stakeholder equity. Rescind industry pre-emptions/entitlements. All clinical trials must report all data.
Please share what you have learned!
Twitter: @JjrkCh

Thursday, October 20, 2011

The goal is safer patients - the tool is transparency!

(link) An implanted joint replacement device must prove that it is better than no device at all.


Hip Surgery Option Loses Key Backer


Injury From Metal Debris in Artificial Hips

All hip implants shed particles as they wear. Over time, debris from plastic components can lead to bone loss and device loosening. But in some patients, researchers believe, metallic debris, which is finer and greater in volume, can set off a different, more aggressive response.Related Article »

No comments:

Post a Comment